Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.82 | ||
| Change(%) | ![]() | +0.01 | |
| Volume | 261532 | ||
| 1:17 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon to Present at NewsMakers in the Biotech Industry Conference
UCB"s Cimzia® Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis
-- Enzon to receive royalties for PEGylation technology--
Enzon Continues to Improve its Capital Structure
-- Company repurchased $17.5 million of its outstanding debt at a discount to par--
Enzon Pharmaceuticals to Add New Independent Director to Board

Enzon Reports Strong First Quarter 2009 Results
--Company continues to improve its capital structure--
Enzon to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow
Enzon Nominates Two New Candidates for its Board of Directors
Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt
